Stella Diagnostics Inc.

OTC: SLDX · Healthcare · Medical - Diagnostics & Research

PublicHQ Salt Lake City, UT · Salt LakeCIK 0001827620Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 18

v0.1 · 5/100 weight · pillars only

↑ Piotroski F, market scale · ↓ Altman-Z, workforce scale

Methodology →

Revenue TTM

$1.8M

Rev growth YoY (TTM)

+774.0%

Net income (FY)

—

Employees

Market cap

$1.0M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Stella Diagnostics Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Suvanza Pharma, LLC——Avenue Therapeutics, Inc.25D Hepion Pharmaceuticals, Inc.25D EVIO, Inc.——

Neighbors

Salt Lake →

Extra Space Storage Inc.$129.5M66B Zions Bancorporation, National Association$529.0M57C HealthEquity, Inc.$1.3B82B+Merit Medical Systems, Inc.$1.5B83B+Rest Ez Inc.$0——PROG Holdings, Inc.$2.4B72B

Key facts

CEODavid Seaburg

SectorHealthcare

IndustryMedical - Diagnostics & Research

HeadquartersSalt Lake City, UT

ExchangeOTC: SLDX

Employees2

IPO date2021-04-16

Latest filings

No filings loaded.

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.